How numbers, nature, and immune status of foxp3(+) regulatory T-cells shape the early immunological events in tumor development
about
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic TargetingTumor-infiltrating dendritic cells in cancer pathogenesisBoosting Tumor-Specific Immunity Using PDTNeoadjuvant anti-tumor vaccination prior to surgery enhances survival.Nuclear FAK controls chemokine transcription, Tregs, and evasion of anti-tumor immunity.Interplay between DNA repair and inflammation, and the link to cancerAryl hydrocarbon receptor ligands in cancer: friend and foe.The Role of Regulatory B Cell-Like Malignant Cells and Treg Cells in the Mouse Model of BCL1 Tumor Dormancy.Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agentEmerging strategies for cancer immunoprevention.Targeting regulatory T cells in tumors.Ontogeny of Tumor-associated CD4+CD25+Foxp3+ T-regulatory Cells.NK Cell Effector Functions Regulation by Modulating nTreg Cell Population During Progressive Growth of Dalton's Lymphoma in Mice.Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection.The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status.Thymus-Derived, Peripherally Derived, and in vitro-Induced T Regulatory Cells.The Aryl Hydrocarbon Receptor and Tumor Immunity.
P2860
Q26742012-FFCA5DAC-5939-4DB1-A86E-522A704F8F00Q26861633-74EC75E1-8E2D-4DC1-BA5F-7685DAF22CD2Q28067203-E38E9FEB-65B6-43AC-818E-BFC860A84B8BQ34145877-E44649F3-8163-4089-B29E-E137874BC766Q34495723-A3B97BF9-C9A5-487A-9058-182BED0BD999Q34989590-E0CA6CBF-8E2B-4F41-A3EA-21685212BA9BQ35458027-15B24C67-1B9E-4B5C-9D69-A9C6FEF167D3Q36222003-866B3403-3D1D-40E4-8EFB-081B3E437D71Q36483712-175D0719-BAFA-4413-894F-C0E00DD86162Q38585850-2B524170-6893-4448-8580-3B0FF4A5B614Q38703565-33A2CA06-F35D-4104-8601-4AC7C4EE8A6AQ38985262-F2CD13C5-55E1-4F5F-A3F2-A6BCB128FB24Q40048056-909789DF-8463-4E01-B258-CFEC4522393CQ41706961-7C40FC80-B723-4170-94DA-5231D3983CD2Q41773489-38B08B1D-85DC-4C03-9437-F500539300D8Q41889070-E57AEDBD-F43F-42AF-BE6F-F0B87834F7C3Q50327400-1EB2FBAD-E9D6-4E8F-8600-D11246BE0FEE
P2860
How numbers, nature, and immune status of foxp3(+) regulatory T-cells shape the early immunological events in tumor development
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
How numbers, nature, and immun ...... al events in tumor development
@en
How numbers, nature, and immun ...... l events in tumor development.
@nl
type
label
How numbers, nature, and immun ...... al events in tumor development
@en
How numbers, nature, and immun ...... l events in tumor development.
@nl
prefLabel
How numbers, nature, and immun ...... al events in tumor development
@en
How numbers, nature, and immun ...... l events in tumor development.
@nl
P2860
P356
P1476
How numbers, nature, and immun ...... al events in tumor development
@en
P2093
Katrina Podsypanina
P2860
P356
10.3389/FIMMU.2013.00292
P577
2013-09-26T00:00:00Z